Navigation Links
Velos, Inc. Appoints William Broucek Senior Director, Professional Services
Date:3/12/2009

FREMONT, Calif., March 12 /PRNewswire/ -- Velos, Inc., the recognized leader and trusted resource for clinical trials management information systems, has appointed William Broucek to the position of Senior Director, Professional Services. Velos developed this role to address needs coming out of its significant growth during the past two years. Broucek was hired to ensure that superior customer service is sustained while its market leadership continues to expand.

"Excellence in meeting the singular needs of each customer has to keep pace with the excellence and reputation of our clinical research software product suite," said John S. McIlwain, President and CEO of Velos. "Broucek is safeguarding that objective as he oversees and directs our front line project managers, supporting them with strong technical expertise and resources."

Broucek is a healthcare software professional with proven success, leading professional services and operations groups to complete implementation projects of all sizes on time and within budget. Previously, Broucek held senior positions in professional services and implementation management with Bay Area companies that include Agistix, iKnowMed, a Division of US Oncology, Oacis Healthcare Systems, and Fritz Companies, Inc.

"We are very pleased to have Bill Broucek as a member of our management team," continued McIlwain. "His excellent interpersonal, analytical and leadership skills have garnered a warm respect among our project managers. This, combined with Bill's solid systems knowledge, adds depth and breadth to the services we can offer to our valued customers."

About Velos

Velos, Inc. is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the U.S. Its customers include 21 of the top 25 academic medical centers and research institutions. Among the 100 largest recipients of NIH clinical research funding, Velos customers receive over 50% of NIH extramural grants. Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. The system fundamentally improves the way data is collected, organized and shared. A pure Internet technology platform, Velos eResearch harnesses advanced powers of the Internet to enable research sites, sponsors, and patients to collaborate in a secure, integrated system platform. System users are freed of redundant data entry and related time delays associated with most clinical research today. With emphasis on workflow, Velos integrates the clinical, administrative and financial information needs of research management. Founded in 1996, Velos is privately held with headquarters in Fremont, California. For more information, visit www.velos.com.

This press release may contain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements.


'/>"/>
SOURCE Velos, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. RoundTable Appoints Senior Healthcare Executives
2. BioMarin Appoints Dr. Henry J. Fuchs as Senior Vice President and Chief Medical Officer
3. Chiltern Appoints Jane Turner as Late Phase Director for Europe
4. American Academy of Orthopaedic Surgeons Appoints Peter Mandell, MD, Chair of the Council on Advocacy
5. Endo Pharmaceuticals Appoints William Montague to Board of Directors
6. Streamline Health Appoints Jay D. Miller to Board of Directors
7. Nyer Medical Appoints Sandra Zimmerman as Chief Financial Officer
8. Cynosure Appoints William T. Kelley as Senior Vice President of International Sales
9. American TeleCare, Inc. (ATI) Appoints Michael A. Brodeur as Chief Financial Officer
10. Laser Therapy Disappoints in Stroke Trial
11. Mardil Inc. Appoints Medical Device Veteran Daniel A. Pelak to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... Chronic stress can have a ... it can weaken the immune system and increase inflammation, both of which raise the ... the adult congenital heart disease program at Harvard-affiliated Massachusetts General Hospital. Chronic stress also ...
(Date:5/5/2016)... Texas (PRWEB) , ... May 05, 2016 , ... ... relationship-marketing firm, honored finalists and winners Tuesday evening, May 3, at the 2016 ... Texas. , Scott Pettigrew, Vice President and Chief Security Officer of HMS, ...
(Date:5/5/2016)... ... ... If you don’t mind a bit of prickly therapy to help combat acne ... treatment that some have called the next great tool in dermatology – microneedling, says ... skin needling, is a procedure using a device covered with tiny, shallow needles to ...
(Date:5/5/2016)... ... May 05, 2016 , ... Pigment Laser Tattoo Removal Center is ... of the new PiQo4™ laser, the first 4-wavelenth picosecond laser to receive FDA Clearance. ... other picosecond laser on the market. Jeremy Miller, Tattoo Artist and former reality ...
(Date:5/5/2016)... GA (PRWEB) , ... May 05, 2016 , ... Liposuction ... (FDRS) 2016 Conference in St. Louis, Missouri at the Marriot St. Louis Airport Hotel. ... Byrd was chosen to address the conference about her unique specialization in treating Lipedema. ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Multiple Myeloma Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Multiple Myeloma epidemiology, Multiple Myeloma market valuations ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Actinic Keratosis Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Actinic Keratosis epidemiology, Actinic Keratosis market valuations ...
(Date:5/3/2016)... , May 3, 2016 BioNovus Innovations ... Institute for Advancing Medical Innovation (IAMI) today announced ... drugs, diagnostics and medical devices. An ... with rights to license, develop and commercialize medical ... "This partnership represents a significant advance ...
Breaking Medicine Technology: